Standout Papers

Rifaximin Treatment in Hepatic Encephalopathy 2010 2026 2015 2020 826
  1. Rifaximin Treatment in Hepatic Encephalopathy (2010)
    Nathan M. Bass, Kevin D. Mullen et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
The gut–liver axis and gut microbiota in health and liver disease
2023 Standout
7 intermediate papers

Works of Muhammad Y. Sheikh being referenced

Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study
2020
Rifaximin Treatment in Hepatic Encephalopathy
2010 Standout

Author Peers

Author Last Decade Papers Cites
Muhammad Y. Sheikh 1293 1282 634 19 1.7k
Donald J. Hillebrand 1101 1138 554 23 1.6k
Rosa María Pérez‐Ayuso 1201 1208 764 31 1.9k
R. Todd Frederick 1243 1319 734 27 1.7k
Carroll B. Leevy 902 903 590 29 1.2k
J Turcotte 981 1112 524 19 2.0k
J P Benhamou 1174 1402 571 49 2.1k
Todd R. Stravitz 1283 1623 769 16 2.0k
Jelica Kurtovic 835 743 230 21 1.3k
D. Robert Dufour 693 592 258 38 1.6k
Stephen E. Congly 1433 714 345 59 1.8k

All Works

Loading papers...

Rankless by CCL
2026